My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format

Send to:

Choose Destination

    Prescrire Int. 2008 Oct;17(97):214.

    Do not use bisphosphonate therapy indefinitely for fracture prevention.

    [No authors listed]

    A placebo-controlled trial showed that the limited clinical benefits of continuing treatment after 5 years do not justify the risk of adverse effects.

    PMID: 19536944 [PubMed - indexed for MEDLINE]

    MeSH Terms, Substances

    MeSH Terms:

    Substances:

    LinkOut - more resources

    Medical:

    Libraries:

    Supplemental Content

    Related articles

    Patient drug information

    • Alendronate (Fosamax®, Fosamax Plus D®)

      Alendronate is used to treat and prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who have undergone menopause ('change of life,' end of menstrual periods) and to treat...

    • Source: AHFS Consumer Medication Information

    All links from this record

    • Compound (MeSH Keyword)

      PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

    • Substance (MeSH Keyword)

      PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

    • Related Articles

      Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.

    Recent activity